看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
# j& G3 ]6 i9 f i5 I8 s; y2 y4 C2 Z! [% o$ n
' c1 i* u3 ^8 \! M
Currently available feasibility data for possible combination strategies.
+ z+ a. E. ]5 e/ d. m$ g8 D————————————————————————————————
* z# b: u- o2 Q1 ]2 z0 GCombination Feasibility according to preliminary data - W' y0 V4 f U: [
——————————————————————————————————# q& n( s8 B6 \1 I; F/ T2 w
Bevacizumab + sorafenib Yes, reduced dose & `7 R! ~: s$ Y% y1 z# m
Bevacizumab + sunitinib† No , @# j; J6 Y. ~# M1 ]9 w3 s
Bevacizumab + temsirolimus Yes
3 F* Q. A. m$ \8 j9 z! c1 mBevacizumab + everolimus Yes 7 \! Z* }, a4 O* m' `6 p& {
Sorafenib + sunitinib ?
0 u% W; r4 J8 [! u9 BSorafenib + temsirolimus Yes, reduced dose
- I- {& H& a. i/ U* l8 ]5 V+ ?Sorafenib + everolimus Yes, reduced dose
2 j7 L; |1 t2 b- k3 F2 B, dSunitinib + temsirolimus† No
. P3 q/ U7 {3 O+ w8 w1 t2 ~Sunitinib + everolimus ? , h, L% K9 d2 |& O. O3 C
Temsirolimus + everolimus ?
8 s* C& f$ E+ z) g————————————————————
. J& v* ]$ y1 n! F†Led to US FDA warning.. E6 c0 Y" s- X1 j" E, W8 E
?: As yet unattempted combination.( @3 e: H9 O" @
|